Orbicular Pharmaceutical Technologies and Apotex Announce Generic Ozempic Development
Orbicular Pharmaceutical Technologies and Apotex have received tentative approval from the USFDA for a generic version of semaglutide (Ozempic). This regulatory milestone aims to increase patient access to this GLP-1 ... Read More